Today’s Stock News Alerts
Stock markets reopened by reeling lower, just after the U.S. Independence Day. On Monday, President Trump doubled down on delaying the July 9 trade deadline to August 1. South Korea and Japan now face 25% tariffs. This happened despite Japan’s Nippon Steel agreeing to buy U.S. Steel (X) for $14.9 billion weeks ago. Myanmar, Laos, South Africa, Kazakhstan, and Malaysia also face tariffs ranging from 25% to 40%.Toyota Motor (TM) and Honda Motor (HMC) also faced stock selling pressure.Beware of iron ore firms, including Cleveland-Cliffs (CLF). Copper prices are under pressure due to the risks of slowing metal demand. Watch out for Freeport-McMoRan (FCX) giving up recent gains.Tesla’s (TSLA) relentless rally likely added on Monday. The stock closed down by 6.60% at $294.54. After CEO Elon Musk said he would move from DOGE to efforts leading Tesla, Musk announced the creation of the American Party.Musk does not have many options to overcome the winding down of electric vehicle tariffs. Without the $7,500 credit, consumers will likely buy gas-powered or hybrid vehicles. Still, Tesla needs a focused leader to push EV unit sales before the credits wind down.In the artificial intelligence sector, watch CoreWeave (CRWV). The firm is spending $9 billion to buy Core Scientific. The all-stock deal will dilute CoreWeave investors. IT also adds data center infrastructure capacity for CoreWeave.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


